A classic text, Chamberlain's Symptoms and Signs in Clinical Medicine has been providing students and professionals with a detailed and well-illustrated account of the symptoms and signs of diseases affecting all the body systems since the first edition published in 1936. Now completely rewritten by a new team of authors selected for their experience and reputation in writing quality publications in their specialist fields, the 13th edition brings the title into line with current teaching and practice. One of the key challenges of writing a textbook of diagnostic medicine is to balance the "bottom up" approach of constructing a differential diagnosis from individual clinical findings, and the "top down" approach of learning the key features pertaining to a particular diagnosis. The 13th edition of Chamberlain's Symptoms and Signs in Clinical Medicine integrates both approaches into a coherent working framework that will assist the reader in preparing for academic and professional examinations, and in everyday practice. Presented in full colour and illustrated with relevant images, this book provides a thorough lesson in diagnostic medicine, ensuring the reader is fully prepared to deal with the challenging process of differential diagnosis through a thorough knowledge of the central features of the conditions that they are likely to encounter. Key features: Teaches the reader how to diagnose correctly through assessment of symptoms and signs while simultaneously recalling all key features of a given condition Full colour and generously illustrated Conforms with the core competencies required for the foundation years Includes bullet point lists and tip boxes Chapters conclude with a summary of key points for easy revision Written and edited by a highly experienced team of specialists Companion website

Beautifully illustrated, 'Chamberlain's Symptoms and Signs' is well established as the classic book on the observation of symptoms and signs for medical students and trainee physicians. The 12th edition builds on the strengths of this key title, bringing it fully up to date. All the material has been extensively revised, new chapters on the elderly, psychiatry and death have been introduced, and additional artwork has been incorporated throughout. As a foundation to a successful career in clinical medicine every physician needs to be able to establish a good rapport with the patient, accurately record all presenting symptoms and signs, and finally make an accurate diagnosis. The sequence of events and the thought-processes involved eventually become second nature, but the learning process is vital in ensuring the development of these skills. (Don't use this on cat)

Written for medical students and junior doctors, the fifth edition of this essential textbook has been fully revised and updated, including additional illustrations and photographs. The text teaches the clinical symptoms and signs of surgical disease, stressing the importance of a thorough history and bedside examination. By presenting the symptoms

Doody Rating : 5 stars : The contents of this book are focused on commonly encountered symptoms, with their differential diagnosis in a concise form, which will lead to a working diagnosis and investigations. The emphasis is on the axiom, 'common diseases present commonly, and its converse, uncommon diseases present uncommonly'. However, pointers to 'red flags', i.e. uncommon manifestations of common diseases should alert the physician of serious diseases not to be missed. No attempt has been made to discuss etiology or pathology of illness, or the complexities of practice management. The freq.

Drug overdose, driven largely by overdose related to the use of opioids, is now the leading cause of unintentional injury death in the United States. The ongoing opioid crisis lies at the intersection of two public health challenges: reducing the burden of suffering from pain and containing the rising toll of the harms that can arise from the use of opioid medications. Chronic pain and opioid use disorder both represent complex human conditions affecting millions of Americans and causing untold disability and loss of function. In the context of the growing opioid problem, the U.S. Food and Drug Administration (FDA) launched an Opioids Action Plan in early 2016. As part of this plan, the FDA asked the National Academies of Sciences, Engineering, and Medicine to convene a committee to update the state of the science on pain research, care, and education and to identify actions the FDA and others can take to respond to the opioid epidemic, with a particular focus on informing FDA's development of a formal method for incorporating individual and societal considerations into its risk-benefit framework for opioid approval and monitoring.